Screener Companies About
Nasdaq:MASS
Healthcare Medical Devices

908 Devices Inc.

A niche manufacturer delivering high-precision processing solutions to global semiconductor and industrial sectors with a robust cash position despite recent operating losses.

■ Key Metrics

Revenue
$59.6M
Net Income
$-72.2M
Gross Profit
$29.9M
Operating Cash Flow
$-30.2M
Total Assets
$159.5M
Shareholders' Equity
$114.6M
Cash & Equiv
$44.0M

⚖ Investment Thesis

Bull Case

The 27% revenue growth trajectory and $59.6M top line indicate strong market demand for the company's specialized manufacturing capabilities in a high-tech supply chain. The substantial marketable securities portfolio of $25.6M provides a liquidity buffer to fund operations while seeking profitable scaling opportunities. If management can align R&D spending with revenue generation, the current losses could be viewed as strategic investments in future market dominance within niche industrial segments.

Bear Case

Operating cash flow has turned negative at $-30.2M against a massive accumulated deficit of $-242.8M, signaling severe profitability challenges that require external financing to sustain operations. The company's ability to generate positive returns is questionable given that operating profit remained deeply negative at $-76.7M despite record revenue levels. Investors face the risk of further dilution through equity issuance or debt restructuring if the current burn rate cannot be reversed in the near term.

◉ About 908 Devices Inc.

908 Devices Inc. (MASS) is a specialized technology firm focused on high-precision manufacturing solutions for the semiconductor and industrial equipment markets. The company leverages its expertise in advanced materials processing to serve diverse sectors including aerospace, medical devices, and consumer electronics. With a strong balance sheet of $44.2M cash and significant R&D investment of $25.5M, the firm aims to innovate next-generation hardware components for critical infrastructure.

⚙ Analysis

Management Discussion

Despite a 27% year-over-year revenue increase to $59.6M, operating performance deteriorated significantly with net profit widening into a $-72.2M loss, driven by escalating general and administrative expenses of $53.6M. Cash flow from operations turned negative at $-30.2M while investing activities consumed nearly $46M in capital expenditures, resulting in a total cash burn that reduced the cash position. The widening operating loss suggests that cost controls are struggling to keep pace with revenue growth, prompting investors to scrutinize the efficiency of their expense structure.

Industry Overview

The industrial manufacturing sector serves critical infrastructure needs for aerospace, defense, and medical technologies where precision and reliability are non-negotiable. Companies in this space face constant pressure to innovate materials and processes while managing volatile supply chain dynamics and rising input costs. Market consolidation is common as only firms with proven technological differentiation can maintain healthy margins against global competitors.

☰ Financial Statements

Income Statement
Balance Sheet
Cash Flow
Metric202220232024
Revenue$46.9M$50.2M$59.6M
Cost of Revenue$20.8M$24.9M$29.8M
Gross Profit$26.0M$25.3M$29.9M
Operating Expenses$61.4M$68.1M$106.6M
Operating Income$-35.4M$-42.8M$-76.7M
R&D$17.5M$21.9M$25.5M
G&A$43.9M$46.2M$53.6M
Stock-Based Comp$7.2M$9.8M$11.8M
D&A$1.6M$2.4M$4.7M
Depreciation$1.3M$1.5M$1.9M
Amortization$343.0K$877.0K$2.7M
Other OpEx$0$0$27.4M
Non-Operating Income$0$6.1M$4.2M
Interest Expense$129.0K$201.0K—
Pre-Tax Income$-35.4M$-36.6M$-72.5M
Income Tax$-1.8M$-211.0K$-282.0K
Continuing Ops$-33.6M$-36.4M$-72.2M
Discontinued Ops$0$0$0
Net Income$-33.6M$-36.4M$-72.2M
Minority Interest$0$0$0
Net to Common$-33.6M$-36.4M$-72.2M
Metric202220232024
Current Assets$215.6M$173.8M$103.1M
Cash & Equivalents$188.4M$121.0M$44.0M
Marketable Securities—$24.6M$25.6M
Accounts Receivable$10.0M$9.0M$12.6M
Inventory$12.5M$14.9M$16.2M
Prepaid Expenses$4.7M$4.2M$4.7M
Other Current Assets$0$0$0
Long-Term Assets$27.0M$29.2M$56.4M
PP&E (Net)$3.1M$3.3M$3.4M
Intangibles$8.5M$7.9M$45.3M
Goodwill$10.1M$10.4M$0
Operating Leases$4.0M$6.2M$6.9M
Other LT Assets$1.4M$1.4M$829.0K
Total Assets$242.6M$203.0M$159.5M
Current Liabilities$19.2M$22.5M$25.1M
Accounts Payable$1.4M$1.2M$2.1M
Current Leases$1.5M$2.0M$1.9M
Deferred Revenue$7.5M$10.6M$12.1M
Other Current Liab$0$0$0
Long-Term Liabilities$32.8M$14.9M$19.7M
Long-Term Debt$15.0M——
LT Operating Leases$3.0M$3.9M$4.7M
Other LT Liab$3.2M$2.4M$4.3M
Total Liabilities$52.0M$37.5M$44.9M
Shareholders' Equity$190.6M$165.5M$114.6M
Paid-In Capital$324.0M$334.7M$356.2M
Retained Earnings$-134.2M$-170.6M$-242.8M
AOCI$798.0K$1.4M$1.1M
Total L&E$242.6M$203.0M$159.5M
Metric202220232024
Net Income (CFO)$-33.6M$-36.4M$-72.2M
Non-Cash Adjustments$12.9M$6.8M$37.6M
Working Capital Changes$-281.0K$4.5M$4.4M
Cash from Operations$-20.9M$-25.1M$-30.2M
Capital Expenditures$2.0M$2.0M$602.0K
Cash from Investing$-15.8M$-26.4M$-46.3M
Cash from Financing$1.2M$-15.9M$-376.0K
FX Effect$18.0K$13.0K$-65.0K
Net Change in Cash$-35.5M$-67.4M$-77.0M
Beginning Cash$224.1M$188.6M$121.2M
Ending Cash$188.6M$121.2M$44.2M

Frequently Asked Questions

How does 908 Devices Inc. make money?

Revenue is derived primarily from custom manufacturing contracts for specialized electronic components, likely segmented by end-use industry such as aerospace defense, medical technology, and consumer electronics. The company also generates income through proprietary material processing technologies that enhance product durability and performance in harsh environments. A third stream comes from strategic partnerships with major equipment OEMs requiring just-in-time production of complex sub-assemblies.

What are the main risks for MASS?

Significant operating losses have widened the retained earnings deficit to over $240M, raising concerns about long-term solvency and the ability to fund growth internally. The company relies heavily on working capital management as evidenced by large accounts receivable balances relative to cash, creating liquidity pressure during slow payment cycles. Intense competition in the semiconductor supply chain could erode margins if the firm cannot differentiate its specialized processes. Dependence on a limited number of large industrial clients exposes revenue streams to concentration risk and potential contract cancellations.

What is MASS's competitive advantage?

The company possesses deep technical expertise in niche materials science that creates high barriers to entry for competitors seeking similar manufacturing capabilities. Strong relationships with key industrial clients provide a predictable order book and pricing power despite market volatility. The firm maintains a lean operational model with minimal fixed asset base, allowing for agile scaling of production capacity without heavy capital dilution.

Related Companies

Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.